Site Map
Site Map of
http://www.researchandmarkets.com
-
Site Map
-
Pharmaceuticals and Healthcare
-
Pharmaceuticals 1
(
Latest Titles
)
Pharmaceuticals 2
Pharmaceuticals 3
Pharmaceuticals 4
Pharmaceuticals 5
Pharmaceuticals 6
-
Generics
<< You are in This Category
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
ACE Inhibitor Intolerance: A major driver of growth for the Aiirbs
static version
printer friendly
Actavis Generics Company Intelligence Report
static version
printer friendly
Actavis IMS Company Profile
static version
printer friendly
pdf version
Algorithms for Visual Design Using the Processing Language
static version
printer friendly
pdf version
An Exploration of Consolidation in the Generics Industry
static version
printer friendly
pdf version
Anti-hypertensives: Patent Defense Strategies - Combating Generic Comp...
static version
printer friendly
Apotex Generics Company Intelligence Report
static version
printer friendly
pdf version
Asia-Pacific Generics
static version
printer friendly
Aspen Pharmacare Generics Company Intelligence Report
static version
printer friendly
Aurobindo Generics Company Intelligence Report
static version
printer friendly
pdf version
Authorized Generics: Look Before you Leap
static version
printer friendly
pdf version
^ Top
B
Barr Pharmaceuticals Generics Company Intelligence Report
static version
printer friendly
Bayesian Analysis of Gene Expression Data
static version
printer friendly
pdf version
Biogenerics: Challenges and Promise
static version
printer friendly
Biosimilars (2009 - 2014)
static version
printer friendly
pdf version
Booming US Generic Drug Market
static version
printer friendly
pdf version
Business Strategies for Different Types of Biogenerics
static version
printer friendly
pdf version
^ Top
C
Cap-Analysis Gene Expression (CAGE): The Science of Decoding Gene Tran...
static version
printer friendly
pdf version
Cipla Generics Company Intelligence Report
static version
printer friendly
Combating Generics: Counter-Generics Strategy, Tactics and Execution
static version
printer friendly
pdf version
Commercial Insight: Antibacterials - Regulations, Resistance & Generic...
static version
printer friendly
pdf version
Commercial Insight: Migraine - Opportunities will Exist in the Wake of...
static version
printer friendly
pdf version
Competitor Analysis: Biogenerics & Therapeutic Proteins
static version
printer friendly
pdf version
Competitor Analysis: Human Growth Hormone (hGH)
static version
printer friendly
pdf version
Current Cardiovascular and Diabetes Blockbusters - Brands at Risk Bewa...
static version
printer friendly
^ Top
D
Dr Reddy's Laboratories Generics Company Intelligence Report
static version
printer friendly
pdf version
Drug Delivery 2000: A Key Company and Market Analysis
static version
printer friendly
Drugs of Tommorrow 2002: Pain
static version
printer friendly
pdf version
Drugs of Tomorrow 2001: Bacterial Infections
static version
printer friendly
^ Top
E
Egis Generics Company Intelligence Report
static version
printer friendly
Emerging Blockbusters: 2009's Most Promising Drugs and the Future of t...
static version
printer friendly
pdf version
Emerging Opportunities in Controlled-Release Generic Drugs
static version
printer friendly
pdf version
Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs 2010
static version
printer friendly
pdf version
European Generic Gastrointestinal Pharmaceutical Markets
static version
printer friendly
pdf version
European Generics
static version
printer friendly
^ Top
F
Follow-On Products as a Defense Against Generics
static version
printer friendly
Front-End Strategies to Meet Generics Challenges and Reduce Pharmaceut...
static version
printer friendly
pdf version
Future Growth Opportunities in Generics: The Impact of Consolidation o...
static version
printer friendly
pdf version
^ Top
G
Gedeon Richter Generics Company Intelligence Report
static version
printer friendly
Generic Benchmarking: Brand Erosion at Patent Expiry
static version
printer friendly
pdf version
Generic Drug Market in Canada
static version
printer friendly
pdf version
Generic Drug Share of Total Market, 1984-2020
static version
printer friendly
pdf version
Generic Pharmaceuticals in Belgium: A Strategic Reference, 2006
static version
printer friendly
pdf version
Generic Series: An Introduction To The Canadian Generics Market - Key ...
static version
printer friendly
pdf version
Generic Strategies in Emerging Markets
static version
printer friendly
pdf version
Generics Defense Strategies: Effective Brand Protection through Patent...
static version
printer friendly
Generics Erosion Patterns in the U.S. Market
static version
printer friendly
pdf version
Generics in Asia-Pacific
static version
printer friendly
Generics in Belgium
static version
printer friendly
Generics in Canada
static version
printer friendly
Generics in China
static version
printer friendly
Generics in Europe
static version
printer friendly
Generics in France
static version
printer friendly
Generics in Germany
static version
printer friendly
Generics in Italy
static version
printer friendly
Generics in Japan
static version
printer friendly
Generics in Spain
static version
printer friendly
Generics in the Animal Health Industry
static version
printer friendly
pdf version
Generics in the Netherlands
static version
printer friendly
Generics in the United Kingdom
static version
printer friendly
Generics in the United States
static version
printer friendly
Generics Review 2000/ 2001
static version
printer friendly
Generics Series: Generics Overview in the Seven Major Markets
static version
printer friendly
pdf version
Generics Series: Generics Trends in the Seven Major Markets and Beyond...
static version
printer friendly
pdf version
Generics Substitution in the Spotlight
static version
printer friendly
Generics will Play an Increasingly Important Role in the Pharma Indust...
static version
printer friendly
pdf version
Generics, Biogenerics and Biosimilars: Media Monitor
static version
printer friendly
pdf version
Generics: Global Industry Guide
static version
printer friendly
Global Generics
static version
printer friendly
Global Generics Guide: Benchmarking the Key Players
static version
printer friendly
Global Generics Guide: Part 2 - Benchmarking Country Markets and Strat...
static version
printer friendly
Global Generics Industry Report
static version
printer friendly
pdf version
Global Healthcare Review - October 2002
static version
printer friendly
Global Healthcare Review - September 2002
static version
printer friendly
Growth Strategies In Generics: Innovative And Aggressive Strategies An...
static version
printer friendly
^ Top
H
Healthcare Review: Immune Disorders and Inflammation - September 2002
static version
printer friendly
Healthcare Review: Infectious Diseases - October 2002
static version
printer friendly
Healthcare Review: Licensing - October 2002
static version
printer friendly
pdf version
Hormonal Contraception: Market Update - Surviving the Generic Threat
static version
printer friendly
Hospira Generics Company Intelligence Report
static version
printer friendly
pdf version
Human Growth Hormone - Delivery Technology Driving Market Growth
static version
printer friendly
^ Top
I
Impact of Generics on the Antidepressant Market
static version
printer friendly
pdf version
Indian Generics, 2008-2012: The Growing Threat to Westernised Markets
static version
printer friendly
pdf version
Indian Global Generics Market Size, 2003-2010
static version
printer friendly
pdf version
^ Top
K
Krka Generics Company Intelligence Report
static version
printer friendly
pdf version
^ Top
L
Lannett Generics Company Intelligence Report
static version
printer friendly
^ Top
M
Market Dynamics 2001: Anti-hypertensives - Aiirbs battle for supremacy...
static version
printer friendly
Market Dynamics 2001: Antidepressants - Absorbing the Impact of Generi...
static version
printer friendly
Market Dynamics 2001: Hormonals
static version
printer friendly
Market Dynamics: HIV - Combating a Market Slowdown
static version
printer friendly
pdf version
Maximising the Drug Lifecycle
static version
printer friendly
pdf version
Mylan Laboratories Generics Company Intelligence Report
static version
printer friendly
^ Top
N
New Dynamics and Challenges in the Generics Market 2007
static version
printer friendly
pdf version
^ Top
O
Oomycete Genetics and Genomics: Diversity, Interactions and Research T...
static version
printer friendly
pdf version
^ Top
P
Par Pharmaceutical Generics Company Intelligence Report
static version
printer friendly
pdf version
Partnering in the Global Generics Industry 2008: A Guide to Companies
static version
printer friendly
pdf version
Perrigo Generics Company Intelligence Report
static version
printer friendly
Pharaceutical Branding Strategies
static version
printer friendly
pdf version
Pliva Generics Company Intelligence Report
static version
printer friendly
Population Genetics and Microevolutionary Theory
static version
printer friendly
pdf version
Practical Defense Strategies for Combating Generics Competition
static version
printer friendly
pdf version
Pricing and Reimbursement Issues for Generics and Biosimilars
static version
printer friendly
pdf version
^ Top
R
Ranbaxy Generics Company Intelligence Report
static version
printer friendly
ratiopharm Generics Company Intelligence Report
static version
printer friendly
Reimbursement in Europe, Japan and the US: The Impact of Cost Shifting...
static version
printer friendly
Retail Pharmacy Price Markups on Generic Drugs
static version
printer friendly
pdf version
^ Top
S
Sandoz - PharmaVitae Generics Profile
static version
printer friendly
pdf version
Sandoz Generics Company Intelligence Report
static version
printer friendly
Sawai Pharmaceuticals Generics Company Intelligence Report
static version
printer friendly
Special Report: Patterns of Generic Erosion: An International Chartboo...
static version
printer friendly
pdf version
Stada Arzneimittel Generics Company Intelligence Report
static version
printer friendly
Strategic Intelligence: The Top 12 Pharmaceutical Companies
static version
printer friendly
Strategic Perspectives 2001: Portfolio Management in the Anti-Fungal M...
static version
printer friendly
Strategic Perspectives: Impact of the Cancer Generics Market
static version
printer friendly
^ Top
T
Teva Pharmaceutical Industries Generics Company Intelligence Report
static version
printer friendly
The Anemia Market: Biogenerics and Second-Generation Products Drive Ch...
static version
printer friendly
pdf version
The Biogenerics Market Outlook: An Analysis of Market Dynamics, Growth...
static version
printer friendly
The Blockbuster Drugs Outlook: Optimum management strategies throughou...
static version
printer friendly
pdf version
The European Generics Outlook: A Country-By-Country Analysis Of Develo...
static version
printer friendly
The Generics Industry in 2005: A New Threat to Pharma
static version
printer friendly
The Generics Outlook 2001
static version
printer friendly
The Pharmaceuticals Industry Market Review
static version
printer friendly
The Top 10 Generics Companies: Strategic Insight, Growth Opportunities...
static version
printer friendly
pdf version
The Top 20 Eastern European Manufacturers Of Generic Pharmaceuticals
static version
printer friendly
pdf version
The Top 60 European Manufacturers Of Generic Pharmaceuticals
static version
printer friendly
pdf version
The World Generic Market Report 2010
static version
printer friendly
pdf version
Therapeutic Proteins: Strategic Market Analysis and Forecasts to 2010
static version
printer friendly
Toward a Biogenerics Market: The Regulatory Conundrum
static version
printer friendly
pdf version
^ Top
U
U.S. Drug Delivery Systems Market: Emerging Technologies, Strategic Al...
static version
printer friendly
U.S. Generic Pharmaceuticals Outlook
static version
printer friendly
pdf version
US and European Prescription Generic Markets: An Examination of Commer...
static version
printer friendly
^ Top
W
Watson Pharmaceuticals Generics Company Intelligence Report
static version
printer friendly
Wockhardt Generics Company Intelligence Report
static version
printer friendly
pdf version
World Generic Drug Markets: Competitive Benchmarking
static version
printer friendly
pdf version
World Generics and Biogenerics Markets
static version
printer friendly
pdf version
^ Top
Z
Zentiva Generics Company Intelligence Report
static version
printer friendly
pdf version
Zydus Cadila Generics Company Intelligence Report
static version
printer friendly
All rights reserved. © copyright 2008 Research and Markets
Terms and conditions
Privacy Policy